This year wasn’t kind to the Nifty Pharma index, which slipped nearly 3% as US pricing pressure, regulatory worries and trade jitters kept the sector on edge. But beneath the gloom, a few pharma ...
Len Yaffe, Kessef Capital Management, joins 'Fast Money' to talk opportunities in the pharma stock space. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results